Status:
COMPLETED
Adverse Neonatal Outcomes with a Shortened Clinical Regimen of Dexamethasone.
Lead Sponsor:
Ricardo A Gutierrez Ramirez, MD, MSc, FACOG
Conditions:
Preterm Birth
Distress Respiratory Syndrome
Eligibility:
FEMALE
18-45 years
Phase:
PHASE2
Brief Summary
Respiratory morbidity, including respiratory distress syndrome (RDS), is a serious complication of preterm birth and the leading cause of early neonatal mortality and disability. The effects of antena...
Detailed Description
Prematurity is a major obstacle to achieving goal 4 of the Millennium Development Goals, given its high contribution to neonatal mortality. The survival chances of premature babies vary significantly ...
Eligibility Criteria
Inclusion
- Delivery of a signed and dated informed consent form.
- Declared willingness to comply with all study procedures and availability during the duration of the study.
- Pregnant patient with 20 or more weeks of gestation determined by USG with clinically diagnosed threat of preterm labor (defined as uterine contractions with sufficient progressive frequency and intensity that allow dilation of the cervix before the 37th week of gestation).
- Pregnant patient admitted and birth in the Maternal and Child Hospital, Labor and Delivery room. Part.
- Delivery carried out at the Teaching Hospital.
- Patient with a diagnosis of premature rupture of membranes under conservative management.
- patient must know how to read and write
- Possess a cell phone or some other means of communication.
- Residing in the city of Tegucigalpa, Honduras.
Exclusion
- Patients under 18 years of age.
- Patient with diagnosed psychiatric illnesses.
- Pregnant patient with threat of preterm birth who is also diagnosed with preeclampsia with data of severity and intrauterine growth restriction.
- Pregnant patient with threat of preterm birth who is also diagnosed with premature rupture of membranes.
- Pregnant patient with threat of preterm birth who is also diagnosed con corioamnionitis.
- Pregnant patient with threat of preterm birth who is also diagnosed with acute abdomen.
- Major fetal malformations
- Fetal death
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 24 2024
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT06569251
Start Date
March 1 2024
End Date
November 24 2024
Last Update
November 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Escuela
Tegucigalpa, Francisco Morazán Department, Honduras, 11101